We are live on ! Find out more
TSS

Two Sigma Securities Portfolio holdings

AUM $861M
1-Year Est. Return 21.33%
This Fund
S&P 500
This Quarter Est. Return
+3.5%
1 Year Est. Return
+21.33%
3 Year Est. Return
+86.85%
5 Year Est. Return
+97.02%
10 Year Est. Return
+293.06%
AUM
$8.28B
AUM Growth
-$2.08B
Cap. Flow
-$2.16B
Cap. Flow %
-26.12%
Top 10 Hldgs %
11.07%
Holding
3,887
New
1,000
Increased
869
Reduced
1,033
Closed
963

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$71.1M
2
LLY icon
Eli Lilly
LLY
+$26.4M
3
ACN icon
Accenture
ACN
+$25M
4
AVGO icon
Broadcom
AVGO
+$16.3M
5
BAC icon
Bank of America
BAC
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 7.72%
2 Consumer Discretionary 2.89%
3 Healthcare 2.83%
4 Communication Services 2.59%
5 Financials 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FXHO
2626
UTime Limited
FXHO
$53.6M
0
TALK icon
2627
Talkspace
TALK
$874M
$33.4K ﹤0.01%
+14,519
New +$41.7K
QUBT icon
2628
Quantum Computing Inc
QUBT
$1.77B
$33.2K ﹤0.01%
+66,159
New +$49.5K
VANI icon
2629
Vivani Medical
VANI
$110M
$32.4K ﹤0.01%
+25,739
New +$44.1K
PMNT
2630
DELISTED
PERFECT MOMENT LTD
PMNT
$32.3K ﹤0.01%
+15,012
New +$42.8K
NOTE
2631
DELISTED
FiscalNote
NOTE
$32.1K ﹤0.01%
1,832
+775
+73% +$12.3K
NA
2632
Nano Labs
NA
$42.2M
$32K ﹤0.01%
+7,192
New +$47.4K
CDIO icon
2633
Cardio Diagnostics
CDIO
$4.68M
$31.6K ﹤0.01%
1,914
+1,350
+239% +$31.8K
INVZ icon
2634
Innoviz Technologies
INVZ
$96.1M
$30.8K ﹤0.01%
33,183
-20,533
-38% -$23K
MCRB icon
2635
Seres Therapeutics
MCRB
$46.3M
$30.7K ﹤0.01%
2,122
+1,078
+103% +$18K
ASXC
2636
DELISTED
Asensus Surgical, Inc.
ASXC
$30.5K ﹤0.01%
+91,480
New +$24.7K
CANG
2637
Cango Inc
CANG
$68.9M
$30.4K ﹤0.01%
+1,820
New +$28.1K
AKTS
2638
DELISTED
Akoustis Technologies Inc
AKTS
$30.3K ﹤0.01%
+229,942
New +$86.6K
LXRX icon
2639
Lexicon Pharmaceuticals
LXRX
$999M
$29.9K ﹤0.01%
+17,771
New +$31.9K
NEOV icon
2640
NeoVolta
NEOV
$110M
$29.8K ﹤0.01%
+11,271
New +$27.3K
CBAT icon
2641
CBAK Energy Technology Ltd
CBAT
$44.6M
$29.6K ﹤0.01%
21,575
+9,376
+77% +$11.8K
LNAI
2642
Lunai Bioworks
LNAI
$10.4M
$29.4K ﹤0.01%
+210
New +$28.6K
MOBX icon
2643
Mobix Labs
MOBX
$30.2M
$29.1K ﹤0.01%
1,775
-3,159
-64% -$72.1K
XERS icon
2644
Xeris Biopharma Holdings
XERS
$1.43B
$29K ﹤0.01%
+12,900
New +$26K
URG
2645
Ur-Energy
URG
$485M
$28.7K ﹤0.01%
20,504
-19,692
-49% -$32.7K
LNZA icon
2646
LanzaTech
LNZA
$62.8M
$28.1K ﹤0.01%
+152
New +$38.7K
OCEA
2647
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
$27.9K ﹤0.01%
+22,852
New +$39K
EGHT icon
2648
8x8 Inc
EGHT
$274M
$27.9K ﹤0.01%
+12,557
New +$30.5K
MATH icon
2649
Metalpha Technology Holding
MATH
$42.4M
$27.9K ﹤0.01%
+20,189
New +$29.5K
BYU
2650
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$27.6K ﹤0.01%
+23,489
New +$28.2K

Similar funds

Two Sigma Securities's Q2 2024 Portfolio in Review

As of Q2 2024, Two Sigma Securities held 3,887 positions worth $8.28B, down 20% from $10.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Two Sigma Securities withdrew a net $2.16B in Q2 2024, closing 963 positions and reducing 1,033 holdings. Its most notable exit was Nike, an estimated $17.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, up from 6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Two Sigma Securities opened a new position in Accenture worth $24.8M.

  • Two Sigma Securities's largest Q2 2024 buy was Accenture: 81,773 shares worth $24.8M.
  • Two Sigma Securities added most to NVIDIA in Q2 2024, an estimated $71.1M increase.
  • Two Sigma Securities's biggest Q2 2024 reduction was Amazon, cutting an estimated $55.1M.
  • Two Sigma Securities fully exited Nike in Q2 2024, selling an estimated $17.5M.
  • Two Sigma Securities's ten largest holdings make up 11% of its $8.28B portfolio in Q2 2024.
  • Two Sigma Securities opened 1,000 new positions and closed 963 in Q2 2024.
  • Two Sigma Securities's portfolio value fell 20% quarter-over-quarter to $8.28B.

Based on Two Sigma Securities's 13F filing for Q2 2024, filed 14 Aug 2024.